Pedro Montes

Pedro Montes

Auto-generated profile, based on publicly available information

Pedro Montes

A Unidad de Investigación Médica en Farmacología , CMN Siglo XXI, IMSS , México , México

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Neuroscience Letters
Verified
Journal Article
Closed access
GMGabriela Moralí
Gabriela Moralí
GLGraciela Letechipía-Vallejo
Graciela Letechipía-Vallejo
ELElisa López-Loeza
Elisa López-Loeza
PMPedro Montes
Pedro Montes
LHLucía Hernández-Morales
Lucía Hernández-Morales
MCMiguel Cervantes
Miguel Cervantes

1 February 2015 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
PMPedro Montes
Pedro Montes
ERElizabeth Ruiz
Elizabeth Ruiz
CRCarolina Rojas
Carolina Rojas
PRPatricia Rojas
Patricia Rojas
Ginkgo biloba extract 761 (EGb 761) is a well-defined extract obtained from Ginkgo biloba leaves according to a standardized method. It has been used extensively for the treatment of diseases related to the central nervous system including neurosensory disturbances, cerebrovascular insufficiency, peripheral vascular disturbances, and degenerative dementia. The potential use of EGb 761 has also been suggested for the treatment of psychiatric disorders such as anxiety and depression, which is discussed in the current review. These disorders constitute a global epidemic with serious economic and social consequences. Current available treatments with synthetic drugs may have some disadvantages and undesired side effects. There are diverse natural extracts that have been used for the treatment of psychiatric disorders due to their therapeutic action and low rate of side effects, such as EGb 761. EGb 761 has the ability to produce neuroprotection due to its chemical composition and the synergy of its components. We describe several neuroprotective mechanisms of action of EGb 761 such as antioxidant effects, modulation of neurotransmission, neuroendocrine regulation, and upregulation of neurotrophic factors, which underlie its potential therapeutic effect on psychiatric disorders. Furthermore, we discuss the therapeutic effects of EGb 761 both in animal models of psychiatric disorders and in clinical studies that include these pathologies. We focus on depression, anxiety, and schizophrenia, as well as the therapeutic action of EGb 761 on dementia in comorbidity with psychiatric disorders. In the current review, we propose the potential use of EGb 761, alone or combined with current medication treatment, for psychiatric disorders.

1 November 2012 in Nutrition
Verified
Journal Article
Closed access
PRPatricia Rojas
Patricia Rojas
PMPedro Montes
Pedro Montes
CRCarolina Rojas
Carolina Rojas
NSNorma Serrano-García
Norma Serrano-García
JRJulio César Rojas-Castañeda
Julio César Rojas-Castañeda

14 February 2019 in Neurological Research
Verified
Journal Article
Closed access
PMPedro Montes
Pedro Montes
RVRosa María Vigueras
Rosa María Vigueras
JRJulio César Rojas-Castañeda
Julio César Rojas-Castañeda
TMTomas Monfil
Tomas Monfil
MCMiguel Cervantes
Miguel Cervantes
GMGabriela Moralí
Gabriela Moralí
Objective: Rats treated with progesterone (P4) after ischemia show an adequate functional performance despite a significant loss of hippocampal pyramidal neurons, suggesting that P4 could favour a permissive microenvironment for cerebral plasticity mechanisms. The possibility of P4 treatment promoting the survival of newly generated hippocampal neurons, in relation to the performance of ischemic rats in a spatial learning task, was assessed in this study. Methods: Adult male rats were subjected to a severe global cerebral ischemia episode (30 min) and treated with P4 or its vehicle at 15 min, 2, 6, 24, 48 and 72 h of reperfusion. From day 4 to 8 post-ischemia 5-bromo-2-deoxyuridine (BrdU) was administered to label proliferating cells. Twenty-one days post-ischemia, the rats were exposed to the Morris water maze to assess behavioral parameters of spatial learning and memory. Subsequently, the brain was perfusion-fixed and immunofluorescence procedures were performed to quantify the number of new mature neurons (BrdU+/NeuN+) in the dentate gyrus (DG) of the hippocampus. Results: Rats subjected to severe global cerebral ischemia and treated with P4 had a significantly better performance in spatial learning-memory tests, than those treated with vehicle, and a significantly higher number of new mature neurons (BrdU+/NeuN+) in the DG. Conclusion: These findings show that post-ischemia P4 treatment, following an episode of severe global cerebral ischemia, promotes the survival of newly generated hippocampal neurons in the DG, which may be one of the mechanisms of cerebral plasticity induced by the hormone, that underlie a successful functional performance in learning and memory tests.

1 January 2011 in Restorative Neurology and Neuroscience
Verified
Journal Article
Closed access
PDF file
GMGabriela Moralí
Gabriela Moralí
PMPedro Montes
Pedro Montes
LHLucía Hernández-Morales
Lucía Hernández-Morales
TMTomás Monfil
Tomás Monfil
CEClaudia Espinosa-Garcia
Claudia Espinosa-Garcia
MCMiguel Cervantes
Miguel Cervantes
Purpose: To assess the long-term neuroprotective effects of progesterone (P $_{4}$ ) and allopregnanolone (ALLO) on functional and morphological parameters of the integrity of the hippocampus, after global cerebral ischemia. Methods: Adult male Sprague-Dawley rats were subjected to a transient severe (20 min) forebrain ischemia (Isch) episode and treated with P $_4$ or ALLO (8 mg/kg i.v.) or its vehicle, at 20 min, 2, 6, 24, 48 and 72 h after ischemia. Rats subjected to Sham procedures, and intact rats were included as non-ischemic controls. Three months after ischemia, both the functional (spatial learning and memory, and reference and working memory), and the morphological integrity (dimensions of the hippocampal formation, thickness of the CA1 subfield, and pyramidal neuron population) of the hippocampus and the medial prefrontal cortex (mPFC) were determined. Results: Treatment with P $_4$ or ALLO significantly reduced the impairment in spatial learning and memory, as well as in reference and working memory, and prevented the narrowing of the hippocampus, otherwise induced by ischemia. This better performance of P $_4$ - and ALLO-treated rats than vehicle (Veh) -treated rats, occurred in spite of a loss of pyramidal neurons in the CA1, CA2, CA3 and hilus subfields of the Ammon's horn (remaining neurons: Isch+Veh: 21.0, 35.6, 44.1, and 40.3%; Isch+P $_4$ : 19.9, 32.2, 41.1, and 32.5%; Isch+ALLO: 25.5, 62.0, 73.7, and 56.7%), and non-significant changes in the mPFC, as compared to the Intact group (100%). Conclusions: Performance of P $_4$ - or ALLO-treated rats in learning and memory tests suggests that these steroids promoted neural conditions accounting for adequate functioning long after ischemia, in spite of the loss of hippocampal pyramidal neurons.

1 January 2012 in Restorative Neurology and Neuroscience
Verified
Journal Article
Closed access
GMGabriela Moralí
Gabriela Moralí
PMPedro Montes
Pedro Montes
IGIgnacio González-Burgos
Ignacio González-Burgos
DVDulce A. Velázquez-Zamora
Dulce A. Velázquez-Zamora
MCMiguel Cervantes
Miguel Cervantes
Purpose: To analyze the cytoarchitectural characteristics of the remaining pyramidal neurons in the hippocampal CA1 subfield of rats, four months after global cerebral ischemia (GCI) and progesterone treatment. Methods: Dendritic arborization, and density and shape of the dendritic spines of CA1 pyramidal neurons in brains of intact rats, or rats submitted 120 days earlier to GCI and treatment with progesterone (8 mg/kg) or its vehicle, at 15 min, and 2, 6, 24, 48, and 72 h after the onset of reperfusion, were analyzed in samples processed by a modified Golgi method. Results: Few impregnated CA1 pyramidal neurons were identified in the ischemic vehicle-treated rats, with a short apical dendrite devoid of bifurcations and dendritic spines. In contrast, the remaining CA1 pyramidal neurons sampled from ischemic progesterone-treated rats showed sinuously branched dendrites with similar number of bifurcations and whole density of spines, and higher proportional density of mushroom spines than those in the intact group. Conclusions: These cytoarchitectural characteristics may underlie the long-term preservation of place learning and memory functions seen after ischemia and progesterone neuroprotective treatment, possibly compensating for the severe reduction in neuronal population.